SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 194 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $0 | -100.0% | 4 | -99.9% | 0.00% | – |
Q1 2023 | $5,000 | – | 7,318 | +910.8% | 0.00% | – |
Q4 2022 | $0 | – | 724 | +2.4% | 0.00% | – |
Q3 2022 | $0 | – | 707 | +1437.0% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 46 | -99.5% | 0.00% | – |
Q1 2022 | $13,000 | -69.8% | 10,040 | -70.5% | 0.00% | – |
Q4 2021 | $43,000 | +30.3% | 33,991 | +129.4% | 0.00% | – |
Q3 2021 | $33,000 | -17.5% | 14,817 | +39.9% | 0.00% | – |
Q2 2021 | $40,000 | +100.0% | 10,592 | +76.4% | 0.00% | – |
Q1 2021 | $20,000 | -83.2% | 6,005 | -82.8% | 0.00% | – |
Q4 2020 | $119,000 | -36.7% | 34,829 | -24.3% | 0.00% | – |
Q3 2020 | $188,000 | +56.7% | 45,993 | +30.0% | 0.00% | – |
Q2 2020 | $120,000 | +21.2% | 35,389 | -16.8% | 0.00% | – |
Q1 2020 | $99,000 | +125.0% | 42,516 | +245.7% | 0.00% | – |
Q4 2019 | $44,000 | +131.6% | 12,299 | +434.7% | 0.00% | – |
Q3 2019 | $19,000 | -5.0% | 2,300 | -0.8% | 0.00% | – |
Q2 2019 | $20,000 | -73.0% | 2,319 | -66.4% | 0.00% | – |
Q1 2019 | $74,000 | +270.0% | 6,902 | +200.1% | 0.00% | – |
Q4 2018 | $20,000 | -96.8% | 2,300 | -93.8% | 0.00% | – |
Q3 2018 | $621,000 | -12.9% | 36,975 | +8.6% | 0.00% | – |
Q2 2018 | $713,000 | +222.6% | 34,041 | +147.7% | 0.00% | – |
Q1 2018 | $221,000 | -18.8% | 13,741 | -4.2% | 0.00% | – |
Q4 2017 | $272,000 | -98.2% | 14,341 | -98.7% | 0.00% | -100.0% |
Q3 2017 | $15,387,000 | +202.8% | 1,093,544 | +60.3% | 0.01% | +133.3% |
Q2 2017 | $5,082,000 | +9.3% | 682,114 | -4.6% | 0.00% | 0.0% |
Q1 2017 | $4,649,000 | +47.4% | 715,251 | +0.5% | 0.00% | +50.0% |
Q4 2016 | $3,153,000 | -21.4% | 711,835 | -17.1% | 0.00% | 0.0% |
Q3 2016 | $4,011,000 | -37.1% | 858,898 | -11.5% | 0.00% | -50.0% |
Q2 2016 | $6,375,000 | -0.5% | 970,332 | -3.7% | 0.00% | 0.0% |
Q1 2016 | $6,410,000 | +1.4% | 1,007,904 | -3.9% | 0.00% | 0.0% |
Q4 2015 | $6,324,000 | +3.8% | 1,048,807 | +3.0% | 0.00% | -20.0% |
Q3 2015 | $6,090,000 | -12.7% | 1,018,331 | -0.2% | 0.01% | 0.0% |
Q2 2015 | $6,978,000 | +13.2% | 1,020,207 | +0.4% | 0.01% | +25.0% |
Q1 2015 | $6,166,000 | -13.7% | 1,015,848 | -1.5% | 0.00% | -20.0% |
Q4 2014 | $7,144,000 | -12.6% | 1,030,882 | +2.7% | 0.01% | -16.7% |
Q3 2014 | $8,174,000 | -3.5% | 1,004,207 | -3.6% | 0.01% | 0.0% |
Q2 2014 | $8,473,000 | +5.9% | 1,042,118 | +2.1% | 0.01% | 0.0% |
Q1 2014 | $8,000,000 | -22.9% | 1,020,425 | -13.0% | 0.01% | -14.3% |
Q4 2013 | $10,381,000 | +11970.9% | 1,173,057 | +11280.1% | 0.01% | – |
Q3 2013 | $86,000 | -7.5% | 10,308 | -17.6% | 0.00% | – |
Q2 2013 | $93,000 | – | 12,508 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |